April 17, 2024

Grand Depart

Experienced In Technology

The Top 25 Healthcare Technology Leaders of Houston for 2023

18 min read
The Top 25 Healthcare Technology Leaders of Houston for 2023

The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Houston for 2023. Houston stands out as a prominent hub for medical device manufacturing, pharmaceuticals, and health research, boasting a thriving ecosystem encompassing over 1,100 well-established life sciences and biotechnology companies. These visionary-led enterprises are spearheading a healthcare revolution.

Notably, the Texas Medical Center, globally renowned as the largest medical complex, serves as a centerpiece. TMC, with its impressive workforce of 106,000 employees, comprising 61 institutions and supported by thousands of volunteers, witnesses a staggering daily influx of over 160,000 individuals. Throughout the year, the campus warmly welcomes more than 7.2 million visitors. This bustling environment underscores Houston’s status as a fertile breeding ground for pioneering healthcare technology, contributing to a combined healthcare and life sciences workforce that surpasses 394,500 employees.

Among the notable individuals recognized on this year’s roster, we have John Overington, who holds the role of Chief Data Officer at Exscientia, a pioneering AI-driven precision medicine firm. Overington boasts an impressive career spanning more than three decades in the realm of drug discovery, where he has been instrumental in crafting foundational data resources crucial for AI-powered drug development. In addition, Norman Sussman has been serving as the Chief Medical Officer of DUREC since 2020, bringing with him a wealth of experience in clinical research and development, cultivated over a remarkable 30-year career in both academic and industry settings. Furthermore, Jeffery Schipper, an industry stalwart with over a quarter-century of experience in engineering and executive roles within prominent Fortune 100 healthcare companies, holds the esteemed position of Co-Founder and Director at Restech. This forward-thinking company is dedicated to revolutionizing reflux management and believes in offering a superior approach to address this medical concern.

Please join us in celebrating The Top 25 Healthcare Technology Leaders of Houston for 2023.

 

1. Sai Yedavelli
Company: LivaNova
Title: Chief Information Officer

Sai Yedavelli is the Chief Information Officer of LivaNova. He first joined the company in 2013 as director of enterprise applications and analytics. LivaNova is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. Their advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.

As a senior technology executive in the healthcare industry, Yedavelli has a passion for transforming the patient experience and making lives better through digital innovation. He has more than 20 years of technology leadership in various global healthcare and medical device
companies, including LivaNova, Cyberonics, and Amgen. Furthemore, with a background as a scientist, Yedavelli brings a unique perspective and understanding to the possibilities for medical technology. He holds a MS in microbiology and immunology.

 

2. John Overington
Company: Exscientia
Title: Chief Data Officer

John Overington is the Chief Data Officer of Exscientia, an AI-driven precision medicine company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Notably, Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting.

Overington has over 30 years of experience in drug discovery and has developed several of the foundation data resources for AI-based drug discovery. After his Ph.D. in Protein Modelling and Structural Bioinformatics at Birkbeck College, University of London, and a postdoc at Imperial Cancer Research Fund (now CRUK), Overington joined Pfizer. This was followed by scientific leadership positions at Inpharmatica, EMBL-EBI, Benevolent AI. He also worked at the Medicines Discovery Catapult, his most recent position prior to joining Exscientia.

 

3. Mohammad Millwala
​​Company: DM Clinical Research
Title: Chief Executive Officer

Mohammad Millwala began his professional career 20 years ago. Today, he is the Chief Executive Officer of DM Clinical Research, a network of clinical trial investigator sites based out of Houston, Texas. They are the link connecting pharmaceutical and research organizations to caring individuals seeking to power the advancement of medicine.

DM Clinical Research works with qualified physicians with a diverse range of specialties — including cardiology, endocrinology, pediatrics, rheumatology, pulmonology and family medicine — and have conducted a wide variety of studies with successful enrollment targets. Millwala got his start in 2003 as a branch manager at Dyna Care Home Health. He graduated from Northeastern Illinois University with an MBA and from Greenwich University with an undergraduate degree.

 

4. Jonathan Abrarpour
​​Company: Empower Pharmacy
Title: Chief Operating Officer

Jonathan Abrarpour serves as Chief Operating Officer at Empower Pharmacy, the nation’s most advanced compounding pharmacy. They are a PCAB®-accredited 503A compounding pharmacy and have a 503B outsourcing facility designed with the FDA’s current good manufacturing practices (CGMPs) in mind. His responsibilities include the management of daily business operations, working closely with department heads and supervisors to support the day-to-day activity of employees.

Abrarpour obtained his Bachelor of Science in Mechanical Engineering from Texas Tech University. After graduating, he spent three years at Conoco Phillips as a hydraulic fracturing engineer, where he also served as a site lead on oil-field operations. He joined Empower Pharmacy in 2015 as an operations director. During his time in this role, he assisted with the creation of many support functions for both manufacturing and administration within the company. He also served as Chief Production Officer propelling Empower forward as a crucial asset to the company.

 

5. Manfredo Thibau
​​Company: PCCA
Title: Chief Financial Officer

Manfredo Thibau is the Chief Financial Office of PCCA, a company that supports the creation of personalized medicine and innovative products that make a difference in patients’ lives. As a complete resource for independent compounding pharmacies and health systems, PCCA provides high-quality products, education and support to more than 3,000 pharmacy members throughout the United States, Canada, Australia and other countries around the world. Incorporated in 1981 by a network of pharmacists, PCCA has supported pharmacy compounding for more than 40 years.

Thibau’s extensive financial background and work experience includes serving as Vice President, Financial Planning & Analysis, for Igloo Products Corporation; Director of Operations Finance for Pentair; and Manager, Business Development, for Eli Lilly and Company in Brazil. Thibau earned an MBA from UNC’s Kenaan-Flagler Business School, a graduate degree in finance from Harvard University and a Bachelor of Laws degree in accounting from Faculdades Milton Campos.

 

6. Benjamin Halladay
​​Company: Esperion
Title: Chief Financial Officer

Benjamin Halladay is the Chief Financial Officer of Esperion. He first joined the company in 2020 as finance manager in Tech Ops. Esperion works hard to make their medicines easy to get, easy to take and easy to have. They discover, develop, and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo.

Halladay has served as the company’s Senior Director, Financial Planning and Analysis since August 2022. Prior to joining the Company in January 2020, Halladay held a variety of finance roles at National Oilwell Varco, BMC Software, and Pfizer. He also holds a CPA license. Halladay graduated with a BA from Syracuse University and an MBA from Fordham Gabelli School of Business.

 

7. Kengo Takishima
​​Company: Baylor Genetics
Title: Chief Executive Officer

Kengo Takishima currently serves as the President and CEO at Baylor Genetics. In his role, Takishima leads the organization to deliver high-quality genetic testing services globally. In addition to delivering genetic tests, Takishima leads the organization to drive innovation to transform people’s health management based on the development of new digital technologies.

Prior to joining BG, Takishima was responsible for leadership roles in corporate strategy, business development, sales & marketing, M&A, private equity, and turn-around management at H.U. Group Holdings, General Electric, Kaleido Holdings, and Mizuho Bank.

Kengo Takishima Insight

“As a trusted partner and pioneer in genetic testing, Baylor Genetics is committed to improving lives by unlocking the power of genetic insights and making genetic testing easier for all. We empower patients and families to make more informed decisions about their health, and help healthcare providers identify, treat, and prevent some of the most complex hereditary disorders and rare diseases. With a 45-year track record of innovation, we continue to expand access to personalized care and help improve health outcomes through deep scientific expertise, carefully curated data, and customer-centric commercial capabilities.”

 

8. Norman Sussman
​​Company: DURECT Corporation
Title: Chief Medical Officer

Norman Sussman joined DURECT as Chief Medical Officer in November 2020. DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program. Sussman has extensive clinical experience and expertise in the field of liver disease and brings over 30 years of clinical research and development experience in academia and industry. Prior to joining DURECT, he was an Associate Professor of Medicine and Surgery at Baylor College of Medicine and a faculty member of Baylor College of Medicine intermittently since 1985.

During that time, Sussman served as a principal investigator for research focused on the assessment and management of acute liver failure and artificial liver support. Sussman gained leadership experience in industry as the Founder and Vice President of both Amphioxus Cell Technologies from 1995 to 2003; and Hepatix, Inc. from 1993 to 1995. Most recently, he has also served in senior leadership roles as a member of the Baylor Faculty Senate and as director of the telehealth program, Project ECHO®, at Baylor St. Luke’s Medical Center. Sussman received his Bachelor of Medicine and Surgery from the University of the Witwatersrand in Johannesburg, South Africa. He then completed his residency at St. Louis University Hospital and his postdoctoral fellowship at Washington University.

 

9. Sanjay Jajoo
​​Company: G-CON Manufacturing
Title: Chief Financial Officer

Sanjay Jajoo is the Chief Financial Officer at G-CON, a company that specializes in the design and construction of advanced cleanroom solutions for a wide range of industries. G-CON works closely with customers and A&Es to provide solutions that meet their specific needs, building PODular cleanrooms offsite, and providing modular and hybrid construction options. Jajoo has over 20 years of leadership experience in finance, spanning various industries and geographies, including 11 years with GE in various roles.

Jajoo has a solid track record of delivering results in areas such as financial planning and analysis, M&A due-diligence, business strategy, commercial operations, global manufacturing and service operations, and business integration. He is also passionate about developing FP&A talent, and driving simplification and automation initiatives to create efficiencies and improve performance. He holds the credentials of CPA, CA, and CMA. He also has a bachelor’s in commerce and economics.

 

10. Stacy Foster
​​Company: OCuSOFT
Title: Chief Business Officer

Stacy Foster is the Chief Business Officer of OCuSOFT. She first joined the company in 2009 as VP of business development. OCuSOFT is a privately-held Richmond, TX USA-based research, development and supply company specializing in eye and skin care that started with a vision to address the needs of those suffering from ocular surface disease with innovative solutions.

Since 1986, OCuSOFT’s commitment to health care professionals and their patients has been unparalleled. Today, the company is most recognized for its #1 doctor recommended a brand of eyelid cleansers, OCuSOFT Lid Scrub, in addition to its standing as the preferred distributor of ophthalmic products and supplies by eye care professionals. Foster earned an MBA from the University of Texas and an undergraduate degree in business administration from Baylor University’s Hankamer School of Business.

 

11. Connie Bormans
​​Company: Gene By Gene
Title: Chief Laboratory Officer

Connie Bormans is the Chief Laboratory Officer at Gene by Gene, a privately owned laboratory located in Houston, TX. Bormans completed her undergraduate studies at Lafayette College and received her PhD in genetics from Texas A&M University, where she developed STR marker panels for use in plant breeding. As a Research Fellow at the University of Texas Health Science Center at Houston, she managed three large scale projects to identify genes related to cardiovascular disease before moving to Gene by Gene.

Over the last 16 years, Bormans created the numerous policies and procedures that enabled the Gene by Gene laboratory to acquire AABB, NYSDOH, and CLIA/CAP accreditations. Her expertise involves assay design, regulatory requirements, high throughput DNA analysis including STR, SNPs and DNA sequencing, relationship testing, clinical diagnostic testing – and, most recently, investigative genetic genealogy use in law enforcement cold cases.

 

12. Jeffery Schipper
​​Company: Restech
Title: Co-Founder and Director

Jeffery Schipper is the Co-Founder and Director of Restech, a company that believes there is a better way to manage reflux. Schipper has a breadth of experience with over 25 years in engineering and executive positions within major fortune 100 healthcare companies. He also has proven success in startup medical technology companies. Schipper, who provides leadership in securing and managing Restech’s patent portfolio, also built Restech’s compliance platform that established regulatory acceptance in 25+ countries worldwide.

Schipper got his start in 1991 as a VP of R&D at IMED/Alaris Medical. From there, he went on to Navius Corporation, before eventually rising to CEO at Sierra Medical Technology, Inc., his most recent position prior to joining Restech. Schipper graduated from the University of San Diego with an MBA and from the University of Wisconsin-Madison with an undergraduate degree in environmental engineering.

 

13. Angeles Borrego
​​Company: Verizon Business Group
Title: Vice President, Commercial Finance

Angeles Borrego is the Vice President of Commercial Finance at Verizon Business Group. She first joined the company in 2021. Verizon Communications is a broadband and telecommunications company that operates 4G LTE and 3G networks as well as provides information and entertainment services. The company serves mass market, business, government, and wholesale customers by delivering broadband and other wireline and wireless communication innovations.

Verizon CommunicationsWireless operates America’s largest wireless network that serves nearly 102 million customers nationwide. Its wireline operations include Verizon Business and Verizon Telecom. Founded in 1983, Verizon Communications is headquartered in New York. Previously, Borrego was a VP of worldwide finance at Cordis. Before that, she served as a finance leader in the Latin America Medical Region at Cardinal Health. Earlier in her career, she worked with Ernst & Young as a senior auditor.

 

14. Bamrom Jonathan
​​Company: Centene Corporation
Title: Vice President, Pharmacy Strategic Initiatives

Bamrom Jonathan is the Vice President of Pharmacy Strategic Initiatives of Centene Corporation, a leading healthcare enterprise that is committed to helping people live healthier lives. The company offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace and the TRICARE program.

Jonathan has 15 years of experience. He began his career in 2008. Before joining Centene Corporation, Jonathan was a VP of pharmacy strategic initiatives at WellCare Health Plans and before that a VP of pharmacy operations & clinical services at Universal American. Jonathan graduated from the University of Houston with a PharmD and from Rice Business-Jones Graduate School of Business with an MBA.

 

15. Erica Rubalcaba
​​Company: BD
Title: Senior Director, National Accounts

Erica Rubalcaba serves as the Senior Director, National Accounts at Becton Dickinson ‘BD’ -Medication Management Solutions BU, one of the largest global medical technology companies in the world. BD and its 65,000 employees have a passion and commitment to help improve patient outcomes, improve the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to better diagnose disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics.

In this role, Rubalcaba brings her 17+ years of Healthcare Technology experience in Executive Sales, Key Account Management and Operational Excellence to help lead core account teams of Sales, Business Process, Customer Success, Clinical Consultant, HIT, Implementation and Support professionals. Rubalcaba graduated from the University of North Carolina at Charlotte with an undergraduate degree in communications and public relations.

Erica Rubalcaba Insight

“The BD Purpose to Advance the World of Health is truly reflective of the active, on-going, and relentless focus on growth through innovation, industry leadership in connected technologies and continuously inspired by the demand for quality. There isn’t a continuum of care across healthcare that a BD Product doesn’t reach. It is a privilege to know the work my team supports will improve not only the lives of my local Houston neighbors but potentially patients in every city across the Nation and country around the world.”

 

16. Erika Taurel
​​Company: Jazz Pharmaceuticals
Title: Vice President, Head of Global Finance

Erika Taurel is the Vice President and Head of Global Finance of Jazz Pharmaceuticals. She first joined the company in 2021. Jazz Pharmaceuticals plc is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. By transforming biopharmaceutical discoveries into novel medicines, they are working to give people around the world the opportunity to redefine what’s possible.

Taurel is a senior finance executive with 20 years of success driving top-line and bottom-line growth at global multinationals: Pfizer Pharmaceuticals, Pfizer Consumer, Jazz Pharmaceuticals and Shell Oil. Notably, she is a change catalyst – who focuses on strategic investments bringing robust analytical frameworks to provoke executive discussion and decision making that strategically transforms companies and their capabilities. Taurel earned an MBA from NYU Stern School of Business, an MA and an undergraduate degree in mathematics from the University of Oxford.

 

17. Raakhee Kumar
​​Company: GRAIL
Title: Vice President, Legal & Chief Compliance Officer

Raakhee Kumar is the Vice President of Legal and Chief Compliance Officer of GRAIL, a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on saving lives and improving health by pioneering new technologies for early cancer detection. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges with Galleri™, a multi-cancer early detection blood test.

Kumar began her career in 2010. Before joining GRAIL, she was a managing lead counsel and general counsel organization in Mckesson Corp. US oncology at McKesson. Before that, she served as a senior commercial and compliance counsel at St. Jude Medical. Earlier in her career, she worked with Baker Botts as an associate. Kumar graduated from Vanderbilt University Law School with a JD in law, from Rice Business – Jones Graduate School of Business with an MBA, from the University of Houston Law Center with an LLM in health law and policy, and from Northwestern University with an undergraduate degree.

 

18. Travis McGrady
​​Company: QuVa Pharma
Title: Vice President, Technical Operations & Operational Excellence

Travis McGrady is the Vice President of Technical Operations and Operational Excellence of QuVa Pharma, a leader in 503B outsourced compounding, serving all 50 states with a full portfolio of sterile, ready-to-administer injectable products. Having nearly 20 years of pharmaceutical experience, McGrady is knowledgeable in cGMP’s and specializes in parenteral drug manufacturing, specifically within Quality and Manufacturing Operations. Prior to QuVa Pharma, McGrady held leadership roles in both Quality and Manufacturing, with Par, JHP Pharmaceuticals supporting the manufacture of sterile and aseptically produced products.

Most recently, McGrady supported a rapidly growing Cell & Gene Therapy site for Lonza, delivering a zero 483, pre-approval inspection, for two critical products. He has a passion for developing and creating high performing teams, across multiple business units, and delivering on the need for continuous improvement. McGrady graduated from the University of Detroit Mercy with an undergraduate degree in biology.

 

19. Isabelle Trevidic
​​Company: Pharm-Olam
Title: Vice President, Global Human Resources & Country Operations

Isabelle Trevidic is the Vice President, Global Human Resources & Country Operations of Pharm-Olam. She first joined the company in 2012 as senior director of global HR & country operations. Pharm-Olam is now Allucent, a global provider of comprehensive drug development solutions for small to mid-sized biotech companies. With more than 30 years of experience in over 60 countries, Allucent’s individualized partnership approach provides experience-driven insights and expertise in early and late-stage development including consulting, clinical operations, biometrics, and clinical pharmacology.

Previously, Trevidic was a finance and business operations controller in emerging markets at Bio-Rad Laboratories. Before that, she served as a controller at Bio-Rad France. Earlier in her career, she worked with Sanofi SA as an internal auditor. Trevidic earned an MBA from ESG (Ecole Superieure de Gestion) – Paris XI and an undergraduate degree in international business administration from IUT (University of Technology) – Paris XI.

 

20. William Lumpkin
​​Company: Agios Pharmaceuticals
Title: Vice President in U.S. Sales and Marketing

William Lumpkin is the Vice President in U.S. Sales and Marketing at Agios Pharmaceuticals. He first joined the company in 2023. Agios is a biopharmaceutical company that is committed to applying its leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds it builds with patient communities, healthcare professionals, partners and colleagues help elevate their thinking and propel their science to new heights. These connections, combined with their cellular metabolism expertise, have fueled the development and approval of its first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies.

Previously, Lumpkin was an executive director, head of new product strategy and business development at Alexion Pharmaceuticals. Before that, he served as a director of integrated health systems at Takeda. Earlier in his career, he worked with Procter & Gamble as a finance manager in oral b manual toothbrushes. Lumpkin earned an MBA from The University of Chicago Booth School of Business and an undergraduate degree in finance from Indiana University Bloomington.

 

21. Nate Kraft
​​Company: Antylia Scientific
Title: Vice President, General Manager, and Global Engineering Leader

Nate Kraft began his professional career 21 years ago. Today, he is the Vice President, General Manager, and Global Engineering Leader at Antylia Scientific. Antylia Scientific serves professionals in biopharma, environmental and life sciences enabling their ongoing quest for superior outcomes that make life better. Working with urgency and purpose, Antylia Scientific brings mission critical products to their customers in support of their quest to discover and manufacture new therapeutics, vaccines, and diagnostics.

Kraft first got his start in 2002 as a senior marketing manager at Sony Electronics. From there, he went on to Belkin, before eventually rising to senior director of product management for global connected Home Software at Honeywell, his most recent position prior to joining Antylia Scientific. Kraft graduated from the University of California, Berkeley, Haas School of Business with an MBA in management technology and from Dartmouth College with an undergraduate degree in creative writing and English literature.

 

22. Rabin Shrestha
​​Company: US Med-Equip
Title: Vice President of Supply Chain

Rabin Shrestha is the Vice President of Supply Chain of US Med-Equip. He first joined the company in 2011 as a purchasing manager. USME partners with top hospitals across the nation to provide the highest quality medical equipment for patients in their care. They are proud to supply movable medical equipment and beds and therapeutic surfaces rented, sold, maintained and managed using the latest technology to help healthcare providers focus on their patients’ healing.

USME provides medical equipment rentals, refurbished equipment sales and services, including manufacturer and ISO-certified biomedical repair and preventative maintenance services, system shutdowns and asset management and tracking. Shrestha earned an MBA from the University of Lincoln and an undergraduate degree in executive management program, risk management, and corporate governance from Henley Business School.

 

23. Lucinda Anglen
​​Company: Healix
Title: Senior Vice President of Pharmacy

In 1994, Lucinda Anglen joined Healix, the premier provider of outpatient infusion management services. Focused on Patient and Physician Peace of Mind for over 30 compassionate years, they offer unparalleled capabilities for optimal patient care, comfort, compliance, and clinical outcomes in an outpatient setting. Their alignment with physicians is core to their business model. With over 300 infusion clinics across the country, they specialize in infectious disease, gastroenterology, neurology, rheumatology, allergy, immunology, and pulmonology.

Anglen’s curriculum vitae includes work as a Homecare Surveyor for the Joint Commission, hospital clinical pharmacist specializing in nutritional support and infectious disease, Nutrition Specialist with B. Braun (formerly known as McGaw), and manager of two home health care companies. Anglen has also served as the Assistant Professor and Clinical Coordinator, Practice Programs at the University of Houston College of Pharmacy. She earned a BS in Pharmacy from the University of Nebraska Medical Center, completed her Pharmacy Practice Residency at Saint Marys Hospital in Rochester, Minnesota, part of the Mayo Clinic, and was awarded her post-baccalaureate Pharm.D. degree from the University of Utah.

 

24. David Bell-Pruitt
​​Company: Novum Pharmaceutical Research Services
Title: Vice President, Clinical Program Management

David Bell-Pruitt is the Vice President of Clinical Program Management of Novum Pharmaceutical Research Services, a leading Contract Research Organization (CRO) since 1972. Novum has been considered one of the world’s leaders in the conduct of clinical trials, from First in Human studies to Late Phase Research requiring patient populations across multiple therapeutic areas. Novum provides bioanalytical services and full-service scientific support in medical writing and statistical analysis. The company is headquartered in Pittsburgh, Pennsylvania with operations in Toronto, North Dakota and Nevada.

Bell-Pruitt has 19 years of experience in clinical research. During this time, he has served in leadership roles throughout clinical, project management, and study management. His experience spans across many different drug delivery formulations (topical, oral, injectable, inhalation, etc.). He has successfully managed diverse teams across different departments, both internally and externally. He is well-versed in study planning and logistics, allowing him to better serve our diverse client base. Bell-Pruitt received his BS in Biomedical Science from Texas A&M University. Additionally, he received his MBA and Master of Healthcare Administration from the University of Houston – Clear Lake.

 

25. Anandita Seth
​​Company: Neurogene
Title: Vice President, Process and Analytical Development

Anandita Seth is the Vice President of Process And Analytical Development of Neurogene Inc. The mission of Neurogene is to turn devastating neurological diseases into treatable conditions to improve the lives of patients and families impacted by these rare diseases. Neurogene is developing novel approaches and treatments to address the limitations of conventional gene therapy in CNS disorders.

This includes selecting a delivery approach to maximize distribution to target tissues and by designing products to maximize potency and purity for an optimized efficacy and safety profile. Seth has 16 years of experience. She began her career in 2007. Before joining Neurogene, Seth was a head of research, technology and viral therapy at Lonza. Before that, she served as a senior research scientist at Stem Cell Innovations. Seth graduated from the University of Massachusetts Amherst with a Ph.D. in molecular and cell biology.

Leave a Reply

Copyright © All rights reserved. | Newsphere by AF themes.
x